Analytical Data
-
Gene name
CABP1
- Application
-
Alternative Names
Caldendrin; Calbrain
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9NZU7
-
Expression Region
Asp238~Arg370
-
Molecular Weight
17kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CABP1 (Calcium Binding Protein 1) is a member of the cabp family, known for its role in calcium signaling pathways, particularly in the nervous system and cardiac tissues. Research on CABP1 has gained momentum due to its potential involvement in various physiological processes and diseases, including neurodegenerative disorders, synaptic plasticity, and cardiac arrhythmias. CABP1 is characterized by its ability to bind calcium ions, which are critical for intracellular signaling, thereby influencing neuronal excitability and muscle contraction. Recent studies have highlighted its role in modulating the activity of ion channels and neurotransmitter receptors, making it a potential target for therapeutic interventions. The production of recombinant CABP1 protein has become essential for elucidating its structure, function, and interactions at the molecular level. By utilizing techniques such as recombinant DNA technology, researchers aim to generate large quantities of CABP1 for in vitro studies, facilitating the discovery of its binding partners and regulatory mechanisms. Understanding the functional dynamics of CABP1 could provide insights into its role in health and disease, paving the way for the development of novel treatments for calcium-related pathologies. Through the study of recombinantly expressed CABP1, researchers aim to unravel its complex biochemical pathways and therapeutic potential, highlighting its significance in both fundamental biology and translational medicine.
